Carregant...
Antibody neutralization of retargeted measles viruses
The measles virus (MV) vaccine lineage is a promising oncolytic but prior exposure to the measles vaccine or wild-type MV strains limits treatment utility due to the presence of anti-measles antibodies. MV entry can be redirected by displaying a polypeptide ligand on the Hemagglutinin (H) C-terminus...
Guardat en:
Autors principals: | , , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
2014
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4123749/ https://ncbi.nlm.nih.gov/pubmed/24725950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2014.01.027 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|